AstraZeneca AB v. Watson Laboratories Inc. > Summary
Court Case Number 1:14-cv-00666
Filing Date May 23, 2014
Court Delaware District Court
Status Unknown
Appeal2017-1778
Plaintiff
Plaintiff Attorneys
4AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English
AstraZeneca
Attorney Name: Charles E. Lipsey
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
Defendant Attorneys
5Watson Laboratories
Attorney Name: Ralph J. Gabric
Crowell & Moring
Watson Laboratories
Attorney Name: Dominick T. Gattuso
Heyman Enerio Gattuso & Hirzel
Actavis (Teva)
Attorney Name: Dominick T. Gattuso
Heyman Enerio Gattuso & Hirzel
Watson Laboratories
Attorney Name: Laura A. Lydigsen
Crowell & Moring
Watson Laboratories
Attorney Name: Yun Wei
McGuireWoods
Counter Claimant
2Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
RE044186 | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method | Apr 30, 2013 |
07951400 | Coated tablet formulation and method | May 31, 2011 |